Published in Mol Psychiatry on July 01, 2005
The molecular neurobiology of depression. Nature (2008) 6.51
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science (2006) 5.89
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol (2008) 4.82
Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann N Y Acad Sci (2010) 3.95
Stress- and allostasis-induced brain plasticity. Annu Rev Med (2011) 3.06
Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci (2006) 2.50
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.91
Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci (2010) 1.90
REDD1 is essential for stress-induced synaptic loss and depressive behavior. Nat Med (2014) 1.77
Acquiring "the Knowledge" of London's layout drives structural brain changes. Curr Biol (2011) 1.60
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry (2006) 1.59
Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry (2011) 1.56
Understanding the potency of stressful early life experiences on brain and body function. Metabolism (2008) 1.55
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience (2009) 1.49
Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat (2009) 1.48
Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry (2009) 1.47
BDNF val66met polymorphism influences motor system function in the human brain. Cereb Cortex (2009) 1.46
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry (2007) 1.33
Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience (2009) 1.33
DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol (2007) 1.21
A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes. Neuropsychopharmacology (2010) 1.21
Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci (2007) 1.18
Neurogenesis and schizophrenia: dividing neurons in a divided mind? Eur Arch Psychiatry Clin Neurosci (2007) 1.12
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12
Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. J Clin Psychiatry (2011) 1.11
Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm (Vienna) (2010) 1.09
Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol Dis (2012) 1.07
Brain derived neurotropic factor in first-episode psychosis. Schizophr Res (2007) 1.07
Imaging genetics of mood disorders. Neuroimage (2010) 1.06
Impact of genetic variant BDNF (Val66Met) on brain structure and function. Novartis Found Symp (2008) 1.06
Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology (2008) 1.05
Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet (2007) 1.03
Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) (2009) 1.02
Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist (2012) 1.01
Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults. PLoS One (2012) 0.99
The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis (2006) 0.99
Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci (2010) 0.99
The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am J Geriatr Psychiatry (2010) 0.98
Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (2010) 0.98
BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity. Transl Psychiatry (2012) 0.98
Cerebellum volume in high-risk offspring from multiplex alcohol dependence families: association with allelic variation in GABRA2 and BDNF. Psychiatry Res (2011) 0.97
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Neurobiology of cognitive aging: insights from imaging genetics. Biol Psychol (2008) 0.96
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96
Molecular actions and clinical pharmacogenetics of lithium therapy. Pharmacol Biochem Behav (2014) 0.94
Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS One (2012) 0.93
Imaging genetics and development: challenges and promises. Hum Brain Mapp (2010) 0.92
A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Front Aging Neurosci (2014) 0.91
BDNF genotype modulates resting functional connectivity in children. Front Hum Neurosci (2009) 0.91
BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Res (2010) 0.91
BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatry (2013) 0.91
Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry (2008) 0.90
BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study. Addict Biol (2012) 0.89
Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet (2012) 0.89
Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging Behav (2009) 0.88
BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS One (2011) 0.88
The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2012) 0.87
BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2008) 0.87
Cortical mapping of genotype-phenotype relationships in schizophrenia. Hum Brain Mapp (2007) 0.87
Imaging genomics and response to treatment with antipsychotics in schizophrenia. NeuroRx (2006) 0.87
Impact of brain-derived neurotrophic factor Val66Met polymorphism on cortical thickness and voxel-based morphometry in healthy Chinese young adults. PLoS One (2012) 0.87
Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm (Vienna) (2011) 0.86
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci (2013) 0.86
Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophr Res (2013) 0.85
BDNF val66met polymorphism affects aging of multiple types of memory. Brain Res (2014) 0.83
Social support in older individuals: the role of the BDNF Val66Met polymorphism. Am J Med Genet B Neuropsychiatr Genet (2008) 0.83
BDNF Val66Met polymorphism influences age differences in microstructure of the Corpus Callosum. Front Hum Neurosci (2009) 0.83
Pathogenesis of depression: Insights from human and rodent studies. Neuroscience (2015) 0.82
Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. Front Neurosci (2013) 0.82
BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry (2011) 0.81
Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers. Neuroimage Clin (2013) 0.81
Potential moderators of physical activity on brain health. J Aging Res (2012) 0.80
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci (2015) 0.80
Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiapine treated first-episode psychosis. Schizophr Res Treatment (2014) 0.79
What keeps a body moving? The brain-derived neurotrophic factor val66met polymorphism and intrinsic motivation to exercise in humans. J Behav Med (2014) 0.79
Association study of gene polymorphisms and depression with abnormal humor in traditional Uighur medicine. BMC Complement Altern Med (2013) 0.78
Mechanisms underlying the antidepressant response and treatment resistance. Front Behav Neurosci (2014) 0.78
Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. J Affect Disord (2016) 0.78
Post-traumatic stress disorder risk and brain-derived neurotrophic factor Val66Met. World J Psychiatry (2016) 0.77
Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology. PLoS One (2012) 0.76
Genetic influences on hippocampal structure and function in recombinant inbred mice. Behav Brain Res (2008) 0.76
BDNF Met66 modulates the cumulative effect of psychosocial childhood adversities on major depression in adolescents. Brain Behav (2014) 0.76
The Role of BDNF-TrkB Signaling in the Pathogenesis of PTSD. J Depress Anxiety (2013) 0.76
Effects of BDNF polymorphism and physical activity on episodic memory in the elderly: a cross sectional study. Eur Rev Aging Phys Act (2015) 0.76
Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder. Bipolar Disord (2015) 0.75
Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies. Cell Mol Neurobiol (2015) 0.75
The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry (2014) 0.75
Evidence for Association between the Brain-Derived Neurotrophic Factor Gene and Panic Disorder: A Novel Haplotype Analysis. Psychiatry Investig (2014) 0.75
Interaction between BDNF rs6265 Met allele and low family cohesion is associated with smaller left hippocampal volume in pediatric bipolar disorder. J Affect Disord (2015) 0.75
Molar loss and powder diet leads to memory deficit and modifies the mRNA expression of brain-derived neurotrophic factor in the hippocampus of adult mice. BMC Neurosci (2016) 0.75
Brain-Derived Neurotrophic Factor (Val66Met) and Serotonin Transporter (5-HTTLPR) Polymorphisms Modulate Plasticity in Inhibitory Control Performance Over Time but Independent of Inhibitory Control Training. Front Hum Neurosci (2016) 0.75
The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study. BMC Psychiatry (2016) 0.75
Investigating the Role of Hippocampal BDNF in Anxiety Vulnerability Using Classical Eyeblink Conditioning. Front Psychiatry (2015) 0.75
A Lack of Correlation between Brain-Derived Neurotrophic Factor Serum Level and Verbal Memory Performance in Healthy Polish Population. Front Neural Circuits (2016) 0.75
Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid in macaques following early life stress and inverse association with hippocampal volume: preliminary implications for serotonin-related function in mood and anxiety disorders. Front Behav Neurosci (2014) 0.75
The BDNF Val(66)Met polymorphism is associated with structural neuroanatomical differences in young children. Behav Brain Res (2017) 0.75
Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science (1981) 23.67
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
N-Acetyl-beta-glucosaminidases in human spleen. Biochem J (1968) 4.92
The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry (1997) 4.79
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Surveys to measure programme coverage and impact: a review of the methodology used by the expanded programme on immunization. World Health Stat Q (1985) 3.61
Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am J Med Genet (1998) 3.37
Standardized remission criteria in schizophrenia. Acta Psychiatr Scand (2006) 3.29
Gel protein stains: silver stain. Methods Enzymol (1984) 3.18
Association of common health symptoms with bullying in primary school children. BMJ (1996) 3.09
Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res (2000) 3.09
Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem (1995) 3.06
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry (2000) 2.93
delta(15)N as an integrator of the nitrogen cycle. Trends Ecol Evol (2001) 2.89
Ancestral Asian source(s) of new world Y-chromosome founder haplotypes. Am J Hum Genet (1999) 2.89
Separation and properties of beta-galactosidase, beta-glucosidase, beta-glucuronidase and N-acetyl-beta-glucosaminidase from rat kidney. Biochem J (1967) 2.75
Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation. Nat Genet (1996) 2.75
Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry (2007) 2.70
Studies in detoxication. 25. The characterization of phenylglucuronide, and its rate of hydrolysis compared with that of phenylsulphuric acid. Biochem J (1949) 2.59
Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients. AJNR Am J Neuroradiol (1992) 2.58
The new drugs (chlorpromazine & reserpine): administrative aspects. 1956. Psychiatr Serv (2000) 2.58
The effect of tropolone on the formation of 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the brain of the mouse. Br J Pharmacol (1969) 2.54
Acute red ear in children: controlled trial of non-antibiotic treatment in general practice. BMJ (1991) 2.52
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44
Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry (1982) 2.43
Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry (1982) 2.42
A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal Biochem (1981) 2.42
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci U S A (1982) 2.39
Polymorphic admixture typing in human ethnic populations. Am J Hum Genet (1994) 2.37
Silver staining methods for polyacrylamide gel electrophoresis. Methods Enzymol (1983) 2.36
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol (1998) 2.32
Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Am J Psychiatry (1997) 2.29
Specificity and multiple forms of beta-galactosidase in the rat. Biochem J (1965) 2.29
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
The alcohologist's addiction. Some implications of having lost control over the disease concept of alcoholism. Q J Stud Alcohol (1972) 2.28
Dual origins of Finns revealed by Y chromosome haplotype variation. Am J Hum Genet (1998) 2.21
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry (2010) 2.21
Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18
Treatment of staphylococcal septic arthritis in rabbits by systemic antibiotics and intra-articular corticosteroids. Ann Rheum Dis (1998) 2.15
Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature (1986) 2.13
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet (2000) 2.08
Effectiveness and safety of rapid clozapine titration in schizophrenia. Acta Psychiatr Scand (2013) 2.08
Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med (1989) 2.07
Oral temperature changes and cognitive decline in Alzheimer patients: a possible association. J Am Geriatr Soc (1994) 2.02
Influence of psychological factors on risk of temporomandibular disorders. J Dent Res (2007) 2.02
Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet (1997) 2.02
Obstetrical care and social patterns in metropolitan Boston. Public Health Rep (1967) 2.01
Provision of home births. BMJ (1992) 1.96
Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax (1990) 1.95
Characterization of human liver alpha-D-mannosidase purified by affinity chromatography. Biochem J (1976) 1.94
Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates. Arch Gen Psychiatry (1983) 1.92
The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav (2003) 1.91
Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell (1987) 1.90
Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol Biol Cell (2012) 1.90
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women. Mol Psychiatry (2007) 1.88
Anchoring the BPRS: an aid to improved reliability. Psychopharmacol Bull (1988) 1.88
Are microorganisms more effective than plants at competing for nitrogen? Trends Plant Sci (2000) 1.87
Variations in expression of mutant beta actin accompanying incremental increases in human fibroblast tumorigenicity. Cell (1982) 1.86
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry (1997) 1.86
Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 1.86
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol (1998) 1.84
The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA (1993) 1.83
Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care (2001) 1.82
Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor. J Neurosci (1985) 1.80
Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet (1999) 1.79
Human mannosidosis--the enzyme defect. Biochem Biophys Res Commun (1972) 1.79
Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry (1999) 1.79
Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci U S A (1987) 1.79
An Asian-Native American paternal lineage identified by RPS4Y resequencing and by microsatellite haplotyping. Ann Hum Genet (1999) 1.78
CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. Cancer Res (1994) 1.77
The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol (2007) 1.76
The cheetah is depauperate in genetic variation. Science (1983) 1.75
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
Pyramidical model of schizophrenia. Schizophr Bull (1990) 1.74
Evolution of science-based uncertainty factors in noncancer risk assessment. Regul Toxicol Pharmacol (1996) 1.74
Repressive control of potassium transport in Escherichia coli. Biochim Biophys Acta (1966) 1.73
Aminomethyl coumarin acetic acid: a new fluorescent labelling agent for proteins. Histochem J (1986) 1.73
Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry (1998) 1.72
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull (1994) 1.71
An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav (1996) 1.70
Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.70
Assessment of newborn baby's temperature by human touch: a potentially useful primary care strategy. Indian Pediatr (1992) 1.69
24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol (1996) 1.69
Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke Prevention Study (AAASPS) experience. J Natl Med Assoc (1996) 1.68
Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst (1998) 1.68
The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry (1987) 1.68
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry (2000) 1.64
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry (1997) 1.64